期刊文献+

盐酸丁咯地尔注射液联合怡开治疗2型糖尿病周围神经病变疗效分析

原文传递
导出
摘要 目的治疗组观察盐酸丁咯地尔注射液联合怡开治疗2型糖尿病周围神经病变的疗效。方法 62例2型糖尿病并发周围神经病变患者随机分为治疗组32例,对照组30例。两组均予以盐酸丁咯地尔200mg溶于250ml生理盐水中静脉滴注,每日1次,治疗组联合怡开40U肌注,每日1次。结果治疗4周后,两组神经症状均得到改善,且治疗组TSS评分改善与对照组比较,差异有统计学意义(P<0.05);治疗组四肢震动感觉阈值改善较对照组明显(P<0.05)。结论盐酸丁咯地尔注射液联合怡开治疗2型糖尿病周围神经病变有较好的疗效。
出处 《苏州大学学报(医学版)》 CAS 北大核心 2010年第3期588-589,共2页 Suzhou University Journal of Medical Science
  • 相关文献

参考文献5

  • 1Ametov AS,Barinov A, Dyck PJ,et al. The sensory symptoms of diabtic polyneuropathy are improved with a-lipoic acid : the SYDNEY trial [ J ]. Diabetes Care, 2003,26 ( 3 ) : 770 - 776.
  • 2Smith RG. Painful diabetic peripheral neuropathy [ J ]. U Am Podiatr Med Assoc, 2007,97(9) :394-401.
  • 3Brownlee M. The pathobiology of diabetic complications: a unifying mechanism[J]. Diabetes, 2005, 54(6):1615-1625.
  • 4王宇石,吕萍,饶明俐.糖尿病周围神经病发病机制探讨[J].中风与神经疾病杂志,2005,22(5):474-476. 被引量:27
  • 5Habib AA, Brannagan TH. Therapeutic strategies for diabetic neuropathy [ J ]. Curr Neurol Neurosci Rep, 2010, 10 (2) :92 - 100.

二级参考文献19

  • 1Piechota G,Malkiewicz J,Karwat ZD. Diabetes mellitus type 2 as a cause of disability[J]. Przegl Epidemiol,2004,58(4):677-82.
  • 2Gabbay KH. Aldose reductase inhibition in the treatment of diabetic neuropathy:where are we in 2004[J]? Curr Diab Rep,2004,4(6) :405-8.
  • 3Price SA, Agthong S, Middlemas AB, et al. Mitogen-activated protein kinase p38 mediates reduced nerve conduction velocity in experimental diabetic neuropathy:interactions with aldose reductase[J]. Diabetes, 2004,53(7) : 1851-6.
  • 4Coste TC,Gerbi A,Vague P,et al. Peripheral diabetic neuropathy and polyunsaturated fatty acid supplementations:natural sources or biotechnological needs[J]? Cell Mol Biol (Noisy-le-grand),2004,50 (7) :845-53.
  • 5Giannini C,Dyck PJ. Basement membrane reduplication and pericyte degeneration precede development of diabetic polyneuropathy and are associated with its severity[J]. Ann Neurol,1995,37(4) :498-504.
  • 6Ziegler D, Sohr CG, Neurooz-Zadeh J. Oxidative stress and antioxidant defense in relation to the severity of diabetic polyneuropathy and cardiovascular autonomic neuropathy[J]. Diabetes Care,2004,27(9) :2178-83.
  • 7Vincent AM, Russell JW, Low P,et al. Oxidative stress in the pathogenesis of diabetic neuropathy [J ]. Endocr Rev, 2004, 25(4):612-28.
  • 8Baydas G,Donder E,Kiliboz M,et al. Neuroprotection by alphalipoic acid in streptozotocin-induced diabetes[J]. Biochemistry (Mosc), 2004,69 (9): 1001-5.
  • 9Ishii H,Koya D,King GL. Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus[J]. J Mol Med,1998,76(1) :21-31.
  • 10Nakamura J,Kato K,Hamada Y,et al. A protein kinase C-betaselective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats[J]. Diabetes, 1999,48(10): 2090-5.

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部